BIORESTORATIVE THERAPIES INC (BRTX) Forecast, Price Target & Analyst Ratings

NASDAQ:BRTX • US0906556065

Current stock price

0.2406 USD
+0 (+0.25%)
At close:
0.2544 USD
+0.01 (+5.74%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIORESTORATIVE THERAPIES INC (BRTX).

Forecast Snapshot

Consensus Price Target

Price Target
$9.69
+ 3,927.43% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.30
Revenue Estimate
420.75K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$9.69
Upside
+ 3,927.43%
From current price of $0.24 to mean target of $9.69, Based on 8 analyst forecasts
Low
$1.01
Median
$9.69
High
$18.90

Price Target Revisions

1 Month
0.00%
3 Months
-26.92%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for BRTX. The average price target is 9.69 USD. This implies a price increase of 3927.43% is expected in the next year compared to the current price of 0.2406.
The average price target has been revised downward by 26.92% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

BRTX Current Analyst RatingBRTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

BRTX Historical Analyst RatingsBRTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
BRTX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BRTX.
In the previous month the buy percentage consensus was at a similar level.
BRTX was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-08-14Roth MKMMaintains Buy -> Buy
2024-06-12Roth MKMMaintains Buy -> Buy
2023-08-14Roth MKMReiterate Buy -> Buy
2022-12-07Roth CapitalInitiate Buy
2022-09-28Maxim GroupInitiate Buy
2021-12-01Roth CapitalInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.30
Revenue Estimate
420.75K
Revenue Q2Q
1,583.00%
EPS Q2Q
52.98%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-28.26%
EPS (1 Month)
0.00%
EPS (3 Months)
-18.00%

Next Earnings Summary

BRTX is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.3 USD and the consensus revenue estimate is 420.75K USD.
The next earnings revenue estimate has been revised downward by 28.26% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
BRTX revenue by date.BRTX revenue by date.
145.8K
21.50%		401K
175.03%		359.7K
-10.30%		1.938M
438.78%		2.359M
21.72%		3.188M
35.14%		121.86M
3,722.46%		142.75M
17.14%		253.12M
77.32%		334.77M
32.26%		506.85M
51.40%
EBITDA
YoY % growth
BRTX ebitda by date.BRTX ebitda by date.
-15.055M
20.13%		-11.366M
24.50%		-15.437M
-35.82%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
BRTX ebit by date.BRTX ebit by date.
-15.221M
19.76%		-11.555M
24.08%		-15.647M
-35.41%		-13.527M
13.55%		-15.252M
-12.75%		57.071M
474.19%		97.189M
70.29%		115.35M
18.69%		187.08M
62.18%		173.4M
-7.31%		280.69M
61.87%
Operating Margin
BRTX operating margin by date.BRTX operating margin by date.
-10,439.51%-2,881.60%-4,350.04%-698.00%-646.55%1,790.18%79.75%80.81%73.91%51.80%55.38%
EPS
YoY % growth
BRTX eps by date.BRTX eps by date.
-3.52
36.62%		-1.16
66.93%		-1.58
-35.74%		-0.77
51.58%		-0.64
16.00%		5.12
896.83%		6.24
21.91%		7.20
15.36%		7.53
4.53%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.30
52.98%		-0.18
40.50%		-0.15
53.64%		-0.15
52.29%
Revenue
Q2Q % growth		420.75K
1,583.00%		459K
51.49%		510K
4,150.00%		548.25K
2,641.25%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-3.81M
20.76%		-3.246M
1.79%		-3.362M
9.34%		-3.431M
10.31%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BRTX Yearly Revenue VS EstimatesBRTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M 500M
BRTX Yearly EPS VS EstimatesBRTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
73.70%
EPS Next 5 Year
45.66%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
85.46%
Revenue Next 5 Year
209.85%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BIORESTORATIVE THERAPIES INC / BRTX Forecast FAQ

What do analysts expect the price target to be for BIORESTORATIVE THERAPIES INC (BRTX)?

8 analysts have analysed BRTX and the average price target is 9.69 USD. This implies a price increase of 3927.43% is expected in the next year compared to the current price of 0.2406.

When does BIORESTORATIVE THERAPIES INC (BRTX) report earnings?

BIORESTORATIVE THERAPIES INC (BRTX) will report earnings on 2026-05-12.

What are the consensus estimates for BIORESTORATIVE THERAPIES INC (BRTX) next earnings?

The consensus EPS estimate for the next earnings of BIORESTORATIVE THERAPIES INC (BRTX) is -0.3 USD and the consensus revenue estimate is 420.75K USD.

Can you provide the consensus rating for BIORESTORATIVE THERAPIES INC stock?

The consensus rating for BIORESTORATIVE THERAPIES INC (BRTX) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.